Berberine hydrochloride

Berberine hydrochloride, also known as berberine hydrochloride, has been used clinically as a heat-clearing, detoxifying and antibacterial drug for a long time. It is often used to treat bacillary dysentery, acute gastroenteritis, chronic cholecystitis, conjunctivitis, suppurative otitis media and other diseases, all of which have significant curative effects.
Berberine hydrochloride has antibacterial effect on hemolytic streptococcus, Staphylococcus aureus, Neisseria gonorrhoeae, Freund's and Shigella dysenteriae, and it can enhance leukocyte phagocytosis. Berberine hydrochloride (commonly known as berberine hydrochloride) has been widely used in the treatment of gastroenteritis, bacillary dysentery, etc., and has a certain effect on tuberculosis, scarlet fever, acute tonsillitis and respiratory tract infection.
Berberine hydrochloride has a broad antibacterial spectrum, and has antibacterial effects on a variety of Gram-positive and negative bacteria in vitro, including hemolytic streptococci, Staphylococcus aureus, and Vibrio cholerae. Meningococcus, Shigella dysenteriae, typhoid bacillus, diphtheria bacillus, etc. have a strong inhibitory effect, inhibiting bacteria at low concentrations and sterilizing at high concentrations. It also has a certain inhibitory effect on influenza virus, amoeba, leptospira, and some skin fungi. In vitro experiments confirmed that berberine can enhance the phagocytosis of leukocytes and liver reticuloendothelial system. Shigella, hemolytic streptococci, and Staphylococcus aureus can easily develop resistance to this product. There is no cross-resistance between this product and penicillin, etc.